Company Profile

Proneurogen Inc
Profile last edited on: 2/11/2020      CAGE: 71UE6      UEI: CC75K29RDV48

Business Identifier: Drug therapies for preventing and treating cognitive impairment and pain caused by inflammation
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1970 North Wentworth Road
Tucson, AZ 85749
Location: Single
Congr. District: 02
County: Pima

Public Profile

Engaging technology based on R&D conducted by the principals while at the University of Arizona, Proneurogen is structured around harnessing the power of peptides to find novel treatments for inflammation related brain disease, such as pain, cognitive impairment, memory loss, TBI and dementia. There is an increasing body of research to indicate brain inflammation as a key component of these diseases. The project being worked on by Proneurogen - PNA-5 - works as a natural anti-inflammatory and neuroprotectant by increasing brain blood flow, decreasing reactive oxygen species production and decreasing pro-inflammatory mechanisms which accelerate the progression of neurodegenerative disease. ProNeurogen's PNA-5 drug candidate improves the effects of the Angiotensin-(1-7) peptide by moving it across the blood-brain-barrier, increasing its half-life and improving its stability.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency